Granulocyte-Macrophage Colony-Stimulating Factor-Deficient Mice Have Impaired Resistance to Blood-Stage Malaria
Open Access
- 1 January 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (1) , 129-136
- https://doi.org/10.1128/iai.69.1.129-136.2001
Abstract
The contribution of granulocyte-macrophage colony-stimulating factor (GM-CSF), a hematopoietic and immunoregulatory cytokine, to resistance to blood-stage malaria was investigated by infecting GM-CSF-deficient (knockout [KO]) mice with Plasmodium chabaudi AS. KO mice were more susceptible to infection than wild-type (WT) mice, as evidenced by higher peak parasitemia, recurrent recrudescent parasitemia, and high mortality. P. chabaudiAS-infected KO mice had impaired splenomegaly and lower leukocytosis but equivalent levels of anemia compared to infected WT mice. Both bone marrow and splenic erythropoiesis were normal in infected KO mice. However, granulocyte-macrophage colony formation was significantly decreased in these tissues of uninfected and infected KO mice, and the numbers of macrophages in the spleen and peritoneal cavity were significantly lower than in infected WT mice. Serum levels of gamma interferon (IFN-γ) were found to be significantly higher in uninfected KO mice, and the level of this cytokine was not increased during infection. In contrast, IFN-γ levels were significantly above normal levels in infected WT mice. During infection, tumor necrosis factor alpha (TNF-α) levels were significantly increased in KO mice and were significantly higher than TNF-α levels in infected WT mice. Our results indicate that GM-CSF contributes to resistance to P. chabaudi AS infection and that it is involved in the development of splenomegaly, leukocytosis, and granulocyte-macrophage hematopoiesis. GM-CSF may also regulate IFN-γ and TNF-α production and activity in response to infection. The abnormal responses seen in infected KO mice may be due to the lack of GM-CSF during development, to the lack of GM-CSF in the infected mature mice, or to both.Keywords
This publication has 74 references indexed in Scilit:
- Effect of granulocyte–macrophage colony‐stimulating factor on the number of leucocytes and course of Listeria monocytogenes infection in naive and leucocytopenic miceImmunology, 1998
- GM‐CSF‐induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM‐CSF and TNFParasite Immunology, 1996
- Plasmodium yoelii in mice: differential induction of cytokine gene expression during hyporesponsiveness induction and restimulationCellular Immunology, 1995
- Dysfunctional monocytes from a patient with disseminatedMycobacterium kansasii infection are activatedin vitro andin vivo by GM-CSFBiotherapy, 1994
- Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro resultsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible miceClinical and Experimental Immunology, 1993
- Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.The Journal of Experimental Medicine, 1987
- Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patientsBritish Journal of Haematology, 1987
- Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.The Journal of Experimental Medicine, 1987
- Dynamic Alteration in Splenic Function during Acute falciparum MalariaNew England Journal of Medicine, 1987